Prevention of SARS‑CoV‑2 Infection: A Liposomal Functional Food Approach

Fatemeh Hosseini, Bahar Bahramimeimandi, Ehsan Raoufi, M. R. Mozafari


Known as COVID‑19, the coronavirus disease is currently a global pandemic caused by the severe acute respiratory syndrome coronavirus‑2.


COVID-19; Liposomal Functional Food; SARS‑CoV‑2 Infection

Full Text:



Gorbalenya AE, Baker SC, Baric R, Groot RJ, Drosten C,

Gulyaeva AA, et al. Severe acute respiratory syndrome‑related

coronavirus: The species and its viruses – a statement

of the Coronavirus Study Group. bioRxiv 2020. doi:


Raoufi E, Hemmati M, Eftekhari S, Khaksaran K, Mahmodi Z,

Farajollahi MM, et al. Epitope prediction by novel

immunoinformatics approach: A state‑of‑the‑art review. Int J

Pept Res Ther 2020;26:1155‑63.

Tregoning JS, Brown ES, Cheeseman HM, Flight KE,

Higham SL, Lemm NM, et al. Vaccines for COVID‑19. Clin

Exp Immunol 2020;202:162‑92.

Kamepalli MD, Fidsa C. How immune T‑Cell augmentation can

help prevent COVID‑19: A possible nutritional solution using

ketogenic lifestyle. Univ Louisville J Respir Infect 2020;4:7.

Khorasani S, Danaei M, Mozafari MR. Nanoliposome

technology for the food and nutraceutical industries. Trends Food

Sci Technol 2018;79:106‑15.

Mozafari MR, Javanmard R, Raji M. Tocosome: Novel drug

delivery system containing phospholipids and tocopheryl

phosphates. Int J Pharm 2017;528:381‑2.

Mozafari MR, Khosravi‑Darani K, Borazan GG, Cui J,

Pardakhty A, Yurdugul S. Encapsulation of food ingredients

using nanoliposome technology. Int J Food Prop 2008;11:833‑44.